Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (101-110 of 339) with videos related to

Pageof 34
Sort By:
Cell Stem Cell|December 4, 2014
Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosisRafael Kramann, Rebekka K Schneider, Derek P DiRocco, et al.
Science (New York, N.Y.)|November 3, 2018
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBNQuinlan L Sievers, Georg Petzold, Richard D Bunker, et al.
Blood Advances|January 31, 2020
A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophiliaMax Jan, Daniel E Grinshpun, Julian A Villalba, et al.
Molecular Cell|October 16, 2007
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2Haifeng Yang, Yoji Andrew Minamishima, Qin Yan, et al.
Plos Medicine|February 15, 2008
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndromeBenjamin L Ebert, Naomi Galili, Pablo Tamayo, et al.
Nature Biotechnology|June 23, 2014
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingDirk Heckl, Monika S Kowalczyk, David Yudovich, et al.
Nature Biotechnology|September 4, 2014
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivationJohn G Doench, Ella Hartenian, Daniel B Graham, et al.
Blood|June 27, 2012
L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathwayElspeth M Payne, Maria Virgilio, Anupama Narla, et al.
JAMA Cardiology|June 9, 2021
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular EventsRomit Bhattacharya, Seyedeh Maryam Zekavat, Md Mesbah Uddin, et al.
The New England Journal of Medicine|July 1, 2011
Clinical effect of point mutations in myelodysplastic syndromesRafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, et al.
Pageof 34

Showing results (101-110 of 339) with videos related to

Sort By:
Pageof 34
Cell Stem Cell|December 4, 2014
Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosisRafael Kramann, Rebekka K Schneider, Derek P DiRocco, et al.
Science (New York, N.Y.)|November 3, 2018
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBNQuinlan L Sievers, Georg Petzold, Richard D Bunker, et al.
Blood Advances|January 31, 2020
A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophiliaMax Jan, Daniel E Grinshpun, Julian A Villalba, et al.
Molecular Cell|October 16, 2007
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2Haifeng Yang, Yoji Andrew Minamishima, Qin Yan, et al.
Plos Medicine|February 15, 2008
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndromeBenjamin L Ebert, Naomi Galili, Pablo Tamayo, et al.
Nature Biotechnology|June 23, 2014
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingDirk Heckl, Monika S Kowalczyk, David Yudovich, et al.
Nature Biotechnology|September 4, 2014
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivationJohn G Doench, Ella Hartenian, Daniel B Graham, et al.
Blood|June 27, 2012
L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathwayElspeth M Payne, Maria Virgilio, Anupama Narla, et al.
JAMA Cardiology|June 9, 2021
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular EventsRomit Bhattacharya, Seyedeh Maryam Zekavat, Md Mesbah Uddin, et al.
The New England Journal of Medicine|July 1, 2011
Clinical effect of point mutations in myelodysplastic syndromesRafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, et al.
Pageof 34